MetLife Investment Management, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 137 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2021$13,190
-90.7%
12,101
-84.5%
0.00%
-100.0%
Q3 2021$142,395
+25.7%
78,239
+82.3%
0.00%0.0%
Q2 2021$113,304
-63.1%
42,918
-49.7%
0.00%
-66.7%
Q1 2021$307,217
+105.2%
85,338
+43.6%
0.00%
+50.0%
Q4 2020$149,718
-10.7%
59,412
-10.7%
0.00%0.0%
Q3 2020$167,615
-47.7%
66,514
-32.0%
0.00%
-50.0%
Q2 2020$320,689
+55.2%
97,771
+16.0%
0.00%
+33.3%
Q1 2020$206,564
-21.7%
84,312
+50.8%
0.00%0.0%
Q4 2019$263,900
-17.8%
55,911
-25.4%
0.00%
-25.0%
Q3 2019$320,957
-26.6%
74,9900.0%0.00%
-20.0%
Q2 2019$437,191
+76.4%
74,990
+16.5%
0.01%
+66.7%
Q1 2019$247,855
+105.9%
64,3780.0%0.00%
+50.0%
Q4 2018$120,387
-41.6%
64,3780.0%0.00%0.0%
Q3 2018$206,010
+3.5%
64,378
-2.4%
0.00%0.0%
Q2 2018$199,000
+36.3%
65,990
+77.1%
0.00%0.0%
Q1 2018$146,000
-42.5%
37,256
-39.3%
0.00%
-33.3%
Q4 2017$254,00061,3750.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2018
NameSharesValueWeighting ↓
Third Security, LLC 9,709,607$60,394,0003.07%
MSD Partners, L.P. 3,410,500$21,213,0001.32%
MILLER VALUE PARTNERS, LLC 4,926,456$30,643,0001.24%
Michael & Susan Dell Foundation 66,749$415,0000.33%
ACUTA CAPITAL PARTNERS, LLC 150,000$933,0000.26%
Piermont Capital Management Inc. 85,500$532,0000.15%
A.R.T. Advisors, LLC 411,547$2,559,0000.14%
EQUITEC PROPRIETARY MARKETS, LLC 96,100$598,0000.14%
Vident Investment Advisory, LLC 204,744$1,274,0000.10%
EQUITEC PROPRIETARY MARKETS, LLC 68,800$428,0000.10%
View complete list of ZIOPHARM ONCOLOGY INC shareholders